Physician and patient tools to improve chronic kidney disease care

American Journal of Managed Care

Volumn 24, Issue 4, 2018, Pages e107-e114

  Sequist, Thomas D ^a,b,c   Holliday, Alison M ^a   Orav, E John ^a   Bates, David W ^a,c,e   Denker, Bradley M ^d,f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c PARTNERS HEALTHCARE   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f Harvard Vanguard Medical Association   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D;

ACCOUNTABLE CARE ORGANIZATION; AGED; AMBULATORY CARE; ARTICLE; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL DECISION SUPPORT SYSTEM; CLINICAL OUTCOME; CLINICAL TRIAL; CONTROLLED STUDY; ELECTRONIC HEALTH RECORD; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GENERAL PRACTITIONER; HEALTH CARE QUALITY; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; LABORATORY TEST; LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NEPHROLOGIST; PARATHYROID HORMONE BLOOD LEVEL; PATIENT CARE; PATIENT DECISION MAKING; PHOSPHATE BLOOD LEVEL; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; TOTAL QUALITY MANAGEMENT; URINALYSIS; VITAMIN BLOOD LEVEL; ATTITUDE TO HEALTH; MASSACHUSETTS; MIDDLE AGED; MULTICENTER STUDY; NEPHROLOGY; ORGANIZATION AND MANAGEMENT; PATIENT REFERRAL; PRACTICE GUIDELINE; PROTOCOL COMPLIANCE; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ELECTRONIC HEALTH RECORDS; FEMALE; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; NEPHROLOGY; PHYSICIANS, PRIMARY CARE; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; REFERRAL AND CONSULTATION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; URINALYSIS;

EID: 85044962353     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038-2047. doi: 10.1001/jama.298.17.2038.
2. Zandi-Nejad K, Brenner BM. Strategies to retard the progression of chronic kidney disease. Med Clin North Am. 2005;89(3):489-509. doi: 10.1016/j.mcna.2004.11.001.
3. Khan S, Amedia CA Jr. Economic burden of chronic kidney disease. J Eval Clin Pract. 2008;14(3):422-434. doi: 10.1111/j.1365-2753.2007.00883.x.
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-1305. doi: 10.1056/NEJMoa041031.
5. Levey AS, Coresh J, Balk E, et al; National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification [correction in Ann Intern Med. 2003;139(7):605]. Ann Intern Med. 2003;139(2):137-147. doi: 10.7326/0003-4819-139-2-200307150-00013.
6. Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline. Ann Intern Med. 2013;158(11):825-830. doi: 10.7326/0003-4819-158-11-201306040-00007.
7. Vassalotti JA, Centor R, Turner BJ, Greer RC, Choi M, Sequist TD; National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Practical approach to detection and management of chronic kidney disease for the primary care clinician. Am J Med. 2016;129(2):153-162.e7. doi: 10.1016/j.amjmed.2015.08.025.
8. Vest BM, York TR, Sand J, Fox CH, Kahn LS. Chronic kidney disease guideline implementation in primary care: A qualitative report from the TRANSLATE CKD study. J Am Board Fam Med. 2015;28(5):624-631. doi: 10.3122/jabfm.2015.05.150070.
9. Allen AS, Forman JP, Orav EJ, Bates DW, Denker BM, Sequist TD. Primary care management of chronic kidney disease. J Gen Intern Med. 2011;26(4):386-392. doi: 10.1007/s11606-010-1523-6.
10. Minutolo R, De Nicola L, Mazzaglia G, et al. Detection and awareness of moderate to advanced CKD by primary care practitioners: A cross-sectional study from Italy. Am J Kidney Dis. 2008;52(3):444-453. doi: 10.1053/j.ajkd.2008.03.002.
11. Boulware LE, Troll MU, Jaar BG, Myers DI, Powe NR. Identification and referral of patients with progressive CKD: A national study. Am J Kidney Dis. 2006;48(2):192-204. doi: 10.1053/j.ajkd.2006.04.073.
12. Stevens LA, Fares G, Fleming J, et al. Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: Evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol. 2005;16(8):2439-2448. doi: 10.1681/ASN.2005020192.
13. Fox CH, Brooks A, Zayas LE, McClellan W, Murray B. Primary care physicians' knowledge and practice patterns in the treatment of chronic kidney disease: An Upstate New York Practice-based Research Network (UNYNET) study. J Am Board Fam Med. 2006;19(1):54-61. doi: 10.3122/jabfm.19.1.54.
14. Ravera M, Noberasco G, Weiss U, et al. CKD awareness and blood pressure control in the primary care hypertensive population. Am J Kidney Dis. 2011;57(1):71-77. doi: 10.1053/j.ajkd.2010.08.022.
15. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005;16(1):180-188. doi: 10.1681/ASN.2004070539.
16. Vassalotti JA, Li S, McCullough PA, Bakris GL. Kidney early evaluation program: A community-based screening approach to address disparities in chronic kidney disease. Semin Nephrol. 2010;30(1):66-73. doi: 10.1016/j.semnephrol.2009.10.004.
17. Dharmarajan SH, Bragg-Gresham JL, Morgenstern H, et al; Centers for Disease Control and Prevention CKD Surveillance System. State-level awareness of chronic kidney disease in the U.S. Am J Prev Med. 2017;53(3):300-307. doi: 10.1016/j.amepre.2017.02.015.
18. Chronic Kidney Disease Surveillance System-United States. CDC website. nccd.cdc.gov/ckd. Updated March 19, 2018. Accessed March 4, 2018.
19. Tseng CL, Kern EF, Miller DR, et al. Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease. Arch Intern Med. 2008;168(1):55-62. doi: 10.1001/archinternmed.2007.9.
20. Drawz PE, Archdeacon P, McDonald CJ, et al. CKD as a model for improving chronic disease care through electronic health records. Clin J Am Soc Nephrol. 2015;10(8):1488-1499. doi: 10.2215/CJN.00940115.
21. Matsushita K, van der Velde M, Astor BC, et al; Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet. 2010;375(9731):2073-2081. doi: 10.1016/S0140-6736(10)60674-5.
22. Chronic kidney disease tests & diagnosis. National Institute of Diabetes and Digestive and Kidney Diseases website. nkdep.nih.gov/learn/testing/understand-gfr.shtml. Published October 2016. Accessed March 4, 2018.
23. Rutkowski M, Mann W, Derose S, et al. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente. Am J Kidney Dis. 2009;53(3 suppl 3):S86-S99. doi: 10.1053/j.ajkd.2008.07.052.
24. Abdel-Kader K, Fischer GS, Li J, Moore CG, Hess R, Unruh ML. Automated clinical reminders for primary care providers in the care of CKD: A small cluster-randomized controlled trial. Am J Kidney Dis. 2011;58(6):894-902. doi: 10.1053/j.ajkd.2011.08.028.
25. Mendu ML, Schneider LI, Aizer AA, et al. Implementation of a CKD checklist for primary care providers. Clin J Am Soc Nephrol. 2014;9(9):1526-1535. doi: 10.2215/CJN.01660214.
26. Szczech LA, Stewart RC, Su HL, et al. Primary care detection of chronic kidney disease in adults with type-2 diabetes: The ADD-CKD Study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease). PLoS One. 2014;9(11):e110535. doi: 10.1371/journal.pone.0110535.
27. Narva AS, Briggs M, Jordan R, Pavkov ME, Burrows NR, Williams DE. Toward a more collaborative federal response to chronic kidney disease. Adv Chronic Kidney Dis. 2010;17(3):282-288. doi: 10.1053/j.ackd.2010.03.006.
28. Whaley-Connell AT, Vassalotti JA, Collins AJ, Chen SC, McCullough PA. National Kidney Foundation's Kidney Early Evaluation Program (KEEP) annual data report 2011: Executive summary. Am J Kidney Dis. 2012;59(3 suppl 2):S1-S4. doi: 10.1053/j.ajkd.2011.11.018.
29. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089-2100. doi: 10.1111/j.1523-1755.2005.00365.x.
30. Levey AS, Inker LA, Coresh J. Chronic kidney disease in older people. JAMA. 2015;314(6):557-558. doi: 10.1001/jama.2015.6753.
31. Sim JJ, Batech M, Danforth KN, Rutkowski MP, Jacobsen SJ, Kanter MH. End-stage renal disease outcomes among the Kaiser Permanente Southern California creatinine safety program (Creatinine SureNet): Opportunities to reflect and improve. Perm J. 2017;21:16-143. doi: 10.7812/TPP/16-143.